UK tribunal should have considered comparator products, Flynn argues

The UK’s Competition Appeal Tribunal was wrong not to consider drug distributor Flynn’s other products as comparators in its excessive pricing ruling despite overturning fines on the company, Flynn’s counsel have argued.


Get unlimited access to all Global Competition Review content